Summary
This prediction ended on 22.11.18 with a price of €62.62. Massive losses of -39.98% were the result for the BUY prediction by tbackenh. tbackenh has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 6.961% | 6.961% | 129.445% | -17.250% |
| iShares Core DAX® | -0,82 % | -2,03 % | 9,73 % | 57,41 % |
| iShares Nasdaq 100 | -1,74 % | -5,35 % | -0,86 % | 80,46 % |
| iShares Nikkei 225® | 1,21 % | 6,38 % | 27,79 % | 62,93 % |
| iShares S&P 500 | -1,17 % | -3,46 % | 0,10 % | 55,84 % |
Comments by tbackenh for this prediction
In the thread Bayer AG diskutieren
Bayer
Wie im Langfristchart erkennbar, bewegte sich die Aktie des Chemie- und Pharma-Riesen von Ende 2011 bis April 2015 stetig aufwärts. Danach folgte eine Abwärtsbewegung. 2017 sehen wir eine kleine, volatilere Auf- und Abwärtsphase. Und genau diese könnte durch die Verteidigung des 256-Tage-GD nun zugunsten einer weiteren Aufwärtsbewegung beendet sein.